Opportunity Information: Apply for RFA CA 17 047
The Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24) funding opportunity (RFA-CA-17-047) is a National Institutes of Health cooperative agreement created under the Beau Biden Cancer Moonshot Initiative. It is tied to a specific Cancer Moonshot scientific priority identified by the Blue Ribbon Panel (Recommendation B), which called for building a translational science network focused exclusively on immunotherapy approaches to treat and prevent adult cancers. In practical terms, this FOA supports the network infrastructure needed to speed up immuno-oncology research by enabling researchers to work together, share data efficiently, standardize how information is captured and analyzed, and make key resources broadly usable across participating teams.
The main purpose of the DMRC is to serve as the central hub for data management, coordination, and resource sharing for the broader IOTN. The network goal is to accelerate discovery of new immune targets and to evaluate innovative immune-based therapies, including combination approaches, aimed at eliminating established cancers in adults or preventing cancers before they occur. Because immunotherapy research often involves complex, multi-site datasets (clinical information, immune profiling, genomics, imaging, biospecimen annotations, and response outcomes), a dedicated center is meant to ensure that data and materials are collected in consistent ways, curated with quality control, and distributed in a manner that supports cross-project comparisons and rapid translation. The DMRC concept also reflects the Cancer Moonshot emphasis on team science: rather than isolated projects, the intention is to create an environment where multiple groups can contribute and benefit from shared standards, shared platforms, and shared outputs.
This opportunity uses the U24 activity mechanism and is structured as a cooperative agreement, meaning NIH expects to have substantial involvement in coordinating the award’s activities compared to a traditional research grant. The funding activity category is Health, and it is listed under CFDA 93.353. The original application closing date was January 16, 2018, and the opportunity was created on October 10, 2017. The listed award ceiling is $750,000, indicating the maximum anticipated budget level under the announcement. The FOA also notes “ExpectedAwards:” but does not provide a specific number in the supplied text.
Eligibility is broad and includes many types of U.S.-based organizations that could realistically operate a national-scale data and resource coordinating center. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities as allowed by NIH policy. The announcement explicitly calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions.
Restrictions related to foreign involvement are clearly stated. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible to apply. At the same time, the FOA allows foreign components as defined in the NIH Grants Policy Statement, which typically means a U.S. applicant can include certain foreign collaborations or performance sites if they meet NIH requirements and are justified, even though a foreign institution cannot be the primary applicant.
Overall, the DMRC U24 is essentially the backbone award for the Immuno-Oncology Translation Network: it is designed to make large-scale immunotherapy translation work faster and more coherent by building the data systems, governance practices, and sharing mechanisms that let multiple research teams operate like a single coordinated enterprise. The expected impact is less about producing one discrete scientific finding and more about enabling many immunotherapy discoveries and evaluations to move forward more efficiently, with better interoperability of datasets and resources, and with stronger collaborative momentum across the network.Apply for RFA CA 17 047
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.353.
- This funding opportunity was created on 2017-10-10.
- Applicants must submit their applications by 2018-01-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $750,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQ)
What is the funding opportunity described here?
This opportunity is the Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24) funding opportunity, identified as RFA-CA-17-047. It is an NIH cooperative agreement created under the Beau Biden Cancer Moonshot Initiative.
What does "IOTN DMRC (U24)" stand for?
IOTN is the Immuno-Oncology Translation Network. DMRC is the Data Management and Resource-Sharing Center. U24 is the NIH activity mechanism used for this award.
What is the main purpose of the DMRC?
The DMRC is intended to function as the central hub for data management, coordination, and resource sharing for the broader IOTN. Its role is to enable efficient collaboration, consistent data collection and curation, and broad sharing of key resources across the network.
What is the overall goal of the Immuno-Oncology Translation Network (IOTN)?
The network goal is to accelerate discovery of new immune targets and evaluate innovative immune-based therapies (including combination approaches) aimed at eliminating established cancers in adults or preventing cancers before they occur.
How does this opportunity relate to the Cancer Moonshot Initiative?
The FOA was created under the Beau Biden Cancer Moonshot Initiative and is tied to a specific Moonshot scientific priority identified by the Blue Ribbon Panel: Recommendation B, which called for building a translational science network focused exclusively on immunotherapy approaches to treat and prevent adult cancers.
Why is a dedicated data management and resource-sharing center needed for immuno-oncology research?
Immunotherapy research often generates complex, multi-site datasets (such as clinical information, immune profiling, genomics, imaging, biospecimen annotations, and response outcomes). The DMRC is meant to ensure these data and materials are collected consistently, curated with quality control, and distributed in ways that support cross-project comparisons and rapid translation.
What kinds of data and research assets does the FOA indicate the DMRC would help coordinate?
Based on the description, the DMRC would support coordination and standardization around multi-site data types including clinical information, immune profiling data, genomics, imaging, biospecimen annotations, and response/outcome data, along with associated resources that need to be broadly usable across participating teams.
What does the FOA emphasize about collaboration and "team science"?
The FOA reflects the Cancer Moonshot emphasis on team science. Rather than isolated projects operating independently, the intention is to create an environment where multiple groups contribute to and benefit from shared standards, shared platforms, shared outputs, and coordinated governance practices.
Is this award focused on producing a single scientific discovery?
No. The expected impact is described as enabling many immunotherapy discoveries and evaluations to move forward more efficiently by providing shared infrastructure, interoperability of datasets and resources, and stronger collaborative momentum across the network.
What is the NIH activity mechanism for this opportunity?
The opportunity uses the U24 activity mechanism.
What does it mean that this opportunity is a "cooperative agreement"?
As a cooperative agreement, NIH expects to have substantial involvement in coordinating the award's activities compared to a traditional research grant.
What is the funding activity category and CFDA number listed for this opportunity?
The funding activity category is Health, and the opportunity is listed under CFDA 93.353.
When was this funding opportunity created?
The opportunity was created on October 10, 2017.
What was the original application closing date?
The original application closing date was January 16, 2018.
What is the award ceiling for this FOA?
The listed award ceiling is $750,000, indicating the maximum anticipated budget level under the announcement.
How many awards are expected?
The FOA includes a field labeled "ExpectedAwards:" but, in the provided information, it does not specify a number.
Who is eligible to apply for this opportunity?
Eligibility is broad and includes many types of U.S.-based organizations, including state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities as allowed by NIH policy.
Does the announcement explicitly mention any additional eligible applicant categories?
Yes. The announcement explicitly calls out Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions.
Are foreign (non-U.S.) institutions eligible to apply as the primary applicant?
No. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply.
Are non-domestic components of U.S. organizations eligible to apply?
No. Non-domestic components of U.S. organizations are also not eligible to apply.
Does the FOA allow any foreign involvement at all?
Yes. The FOA allows foreign components as defined in the NIH Grants Policy Statement. This generally means a U.S. applicant may include certain foreign collaborations or performance sites if they meet NIH requirements and are justified, even though a foreign institution cannot be the primary applicant.
What is the DMRC described as within the IOTN?
The DMRC U24 is described as the backbone award for the Immuno-Oncology Translation Network, designed to make large-scale immunotherapy translation work faster and more coherent by building the data systems, governance practices, and sharing mechanisms needed for coordinated operation across multiple research teams.
Browse more opportunities from the same category: Health
Next opportunity: Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01, Clinical Trial Optional)
Previous opportunity: Community Food Projects Competitive Grant Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 17 047
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 17 047) also looked into and applied for these:
| Funding Opportunity |
|---|
| Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional) Apply for PA 18 322 Funding Number: PA 18 322 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional) Apply for PA 18 323 Funding Number: PA 18 323 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Announcement of Anticipated Availability of Funds for Support for Expectant and Parenting Teens, Women, Fathers, and Their Families Apply for AH SP1 18 001 Funding Number: AH SP1 18 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,000,000 |
| NHLBI Program Project Applications (P01 - Clinical Trials Optional) Apply for PAR 18 405 Funding Number: PAR 18 405 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maintaining Immunity After Immunization (U01 - Clinical Trial Optional) Apply for RFA AI 17 034 Funding Number: RFA AI 17 034 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed) Apply for PAR 18 329 Funding Number: PAR 18 329 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed) Apply for PAR 18 326 Funding Number: PAR 18 326 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Immunity in the Elderly (R01) Clinical Trial Optional Apply for RFA AI 17 037 Funding Number: RFA AI 17 037 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional) Apply for RFA AG 18 019 Funding Number: RFA AG 18 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 18 406 Funding Number: PAR 18 406 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Role of Peripheral Proteostasis on Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 020 Funding Number: RFA AG 18 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) - Clinical Trial Required Apply for PAR 18 407 Funding Number: PAR 18 407 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 18 410 Funding Number: PAR 18 410 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) - Clinical Trial Not Allowed Apply for PA 18 408 Funding Number: PA 18 408 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) - Clinical Trial Not Allowed Apply for PA 18 409 Funding Number: PA 18 409 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) - (Clinical Trials Not Allowed) Apply for RFA HL 18 026 Funding Number: RFA HL 18 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Program Achievements to Control the Epidemic (APACE) in South Africa Apply for 72067418RFA00001 Funding Number: 72067418RFA00001 Agency: South Africa USAID-Pretoria Category: Health Funding Amount: $600,000,000 |
| Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional) Apply for PAR 18 029 Funding Number: PAR 18 029 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional) Apply for PAR 18 205 Funding Number: PAR 18 205 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Phase III Clinical Trials for the Spectrum of Alzheimer's Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) Apply for PAR 18 028 Funding Number: PAR 18 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 17 047", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
